The Role of Statins in Vascular Disease
Authors:
- R.A FitridgeRFR.A Fitridge
- 1 January 2004
- journal article
- review article
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 27 (1) , 6-16
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic MiceStroke, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998
- Stroke, Statins, and CholesterolStroke, 1997
- Reduction of Serum Cholesterol Levels Alters Lesional Composition of Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Vascular risks of asymptomatic carotid stenosis.Stroke, 1991
- MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosisThe Lancet, 1991
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986